With funding from NSF and other organizations, we are commercializing a disruptive solution that simultaneously disinfects and mitigates organics in difficult-to-treat fluids at up to 20X lower cost than alternatives without chemical additives
Fort Collins, Colorado (PRWEB) January 11, 2017
Symbios Technologies, Inc., a world-leading developer of dynamic aqueous plasma technology platforms, announced today that the National Science Foundation (NSF) has awarded Symbios a Small Business Innovation Research (SBIR) Phase IIB supplement for $500,000. The funds will be used to commercialize the Symbios Tubular Plasma Reactor™ (TPR™) by scaling the system for first customer deployment to treat industrial process and wastewater.
Symbios’ original SBIR Phase II project “Advancing a Novel Low-voltage Electric Arc Method to Oxidize Organic Material in Contaminated Water,” NSF Award ID 1256582, will be extended through the Phase IIB supplement and will continue to focus on productization and commercialization of the TPR platform for final scale-up and field trials with a large industrial end customer. The new funding will enable more robust system automation, user interface, safety enclosure, and new plasma electrode features as well as initiate the regulatory approval process.
“Symbios’ mission ‘to improve human and environmental health through products that harness plasma technology’ has garnered interest from companies in Food and Beverage, Pharmaceutical, Chemical, Bioscience, Power, and Municipal industries around the globe and has been made possible by research funded by the NSF SBIR program,” said Justin Bzdek, Symbios President and CEO and Principal Investigator on the project. “With funding from NSF and other organizations, we are commercializing a disruptive solution that simultaneously disinfects and mitigates organics in difficult-to-treat fluids at up to 20X lower cost than alternatives without chemical additives.”
“Our objective in requesting the Phase IIB funding was to provide additional R&D resources to further accelerate commercialization of the TPR,” continued Bzdek. “With strong support from industry and academic organizations that understand the value of our patented plasma technology and an excellent work plan put together by the Symbios team, we are grateful for the NSF award that matches 1 dollar for every 2 dollars of financial commitments from our commercial partners.”
About Symbios Technologies
Symbios Technologies, Inc. is a world-leading developer of dynamic aqueous plasma technology platforms for water treatment, specialty manufacturing, and biotherapeutic applications. The company, working with its university, government, and industrial partners, is commercializing its disruptive advanced low-cost aqueous plasma oxidation technology, the Symbios Tubular Plasma Reactor™ (TPR4000™), to clean water, preserve the environment, and protect human health while improving production economics and sustainability. Symbios Technologies’ modular reactor is low in capital cost, able to replace existing energy-hungry or poor-performing advanced oxidation processes, while reducing or eliminating the use of biocides and/or chemical additives, thus improving the overall maintenance cost of water treatment systems. The TPR4000 also has the potential to generate less toxic chemotherapy drugs and safer anti-infectives to reduce the global impact of deadly diseases. For more information, go to http://www.symbiosplasma.com/.
About the National Science Foundation's Small Business Programs
The National Science Foundation (NSF) awards nearly $190 million annually to startups and small businesses through the Small Business Innovation Research (SBIR)/Small Business Technology Transfer (STTR) program, thus transforming scientific discovery into products and services with commercial and societal impact. The non-dilutive grants support research and development (R&D) across all areas of science and technology, helping companies de-risk technology for commercial success. The NSF is an independent federal agency with an annual budget of about $7 billion that supports fundamental research and education across all fields of science and engineering.